Adverse events and technical complaints related to surgical sutures marketed in Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Vigilância Sanitária em Debate |
Texto Completo: | https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/25 |
Resumo: | Surgical suture (SS) is a medical material used invasively for positioning biological tissues and is regarded as a critical product due to its contact with skin, vessels and other tissues. The present study aimed to critically analyze the Brazilian National Adverse Event and Product Complaint Reporting (Notivisa) data related to SS. Descriptions of reports made between 2006 and 2009 were thoroughly evaluated. There were 256 reports associated with SS, of which 94 (36.7%) were related to adverse events and 162 (63.3%) to product complaints. The analysis of Notivisa data showed some conceptual inconsistencies and incomplete reports. Most reports were related to suture products including low tensile strength and breaking as well as problems with suture needles. The reports analyzed involved 51% of surgical suture companies doing business in Brazil and there was more than one reporting for 28 batches. These findings stress the importance of implementing a compulsory product certification system with mandatory minimum quality requirements and show a need for ongoing training of those involved in the reporting process. More accurate, faster reporting process would support timely action by health surveillance agents and product companies to prevent or minimize unfavorable health outcomes in the exposed populations. |
id |
FIOCRUZ-9_ec711584027ccf8e9005d6ccd4947730 |
---|---|
oai_identifier_str |
oai:ojs.visaemdebate.incqs.fiocruz.br:article/25 |
network_acronym_str |
FIOCRUZ-9 |
network_name_str |
Vigilância Sanitária em Debate |
repository_id_str |
|
spelling |
Adverse events and technical complaints related to surgical sutures marketed in BrazilEventos adversos e queixas técnicas relacionados ao fio para sutura cirúrgica comercializado no Brasilsurgical suturestechnical surveillancesanitary surveillancenotivisafio para sutura cirúrgicatecnovigilânciavigilância sanitárianotivisaSurgical suture (SS) is a medical material used invasively for positioning biological tissues and is regarded as a critical product due to its contact with skin, vessels and other tissues. The present study aimed to critically analyze the Brazilian National Adverse Event and Product Complaint Reporting (Notivisa) data related to SS. Descriptions of reports made between 2006 and 2009 were thoroughly evaluated. There were 256 reports associated with SS, of which 94 (36.7%) were related to adverse events and 162 (63.3%) to product complaints. The analysis of Notivisa data showed some conceptual inconsistencies and incomplete reports. Most reports were related to suture products including low tensile strength and breaking as well as problems with suture needles. The reports analyzed involved 51% of surgical suture companies doing business in Brazil and there was more than one reporting for 28 batches. These findings stress the importance of implementing a compulsory product certification system with mandatory minimum quality requirements and show a need for ongoing training of those involved in the reporting process. More accurate, faster reporting process would support timely action by health surveillance agents and product companies to prevent or minimize unfavorable health outcomes in the exposed populations.O fio para sutura cirúrgica (FPS) é um produto médico invasivo utilizado para aproximação de tecido biológico e, devido ao contato com a pele, vasculatura e outros tecidos, é considerado um produto crítico. O presente estudo objetivou a análise crítica dos dados do Sistema Nacional de Notificações de Eventos Adversos e Queixas Técnicas (Notivisa), relacionados aos FPSs, através de avaliação minuciosa da descrição das notificações realizadas entre 2006 e 2009. Foram registradas 256 ocorrências associadas ao FPS, sendo 94(36,7%) episódios de eventos adversos e 162(63,3%) de queixas técnicas. Algumas divergências conceituais e registros incompletos foram observados. Merecem destaque as notificações relacionadas ao próprio fio, como seu rompimento e sua baixa resistência, assim como alterações relacionadas à agulha acoplada ao FPS. Verificou-se que 51% das empresas detentoras de registro de FPS no Brasil apresentaram alguma notificação no Notivisa e que, ao todo, 28 lotes apresentaram mais de uma notificação. Esses dados reforçam a importância da implementação da certificação compulsória para esses produtos, estabelecendo requisitos mínimos de qualidade obrigatórios, e demonstram a necessidade de permanente capacitação dos profissionais envolvidos no processo de notificação. Desse modo, a notificação mais rápida e precisa auxiliaria a tomada de medidas oportunas pelo SNVS e pelo detentor do registro, de forma a impedir, ou minimizar, a ocorrência de agravos à saúde das populações expostas.Instituto Nacional de Controle de Qualidade em Saúde2013-05-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/mswordapplication/mswordapplication/mswordapplication/mswordhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/2510.3395/vd.v1n2.25Health Surveillance under Debate: Society, Science & Technology ; Vol. 1 No. 2 (2013): May; 35-43Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 1 Núm. 2 (2013): Puede; 35-43Vigil Sanit Debate, Rio de Janeiro; v. 1 n. 2 (2013): Maio; 35-432317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/25/27https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/25/582https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/25/583https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/25/584https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/25/585Copyright (c) 2013 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessMorais, Luciene de OliveiraFriedrich, KarenMelchior, Stela CandiotoSilva, Michele FeitozaGemal, André LuisDelgado, Isabella Fernandes2023-06-27T14:55:08Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/25Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T14:55:08Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Adverse events and technical complaints related to surgical sutures marketed in Brazil Eventos adversos e queixas técnicas relacionados ao fio para sutura cirúrgica comercializado no Brasil |
title |
Adverse events and technical complaints related to surgical sutures marketed in Brazil |
spellingShingle |
Adverse events and technical complaints related to surgical sutures marketed in Brazil Morais, Luciene de Oliveira surgical sutures technical surveillance sanitary surveillance notivisa fio para sutura cirúrgica tecnovigilância vigilância sanitária notivisa |
title_short |
Adverse events and technical complaints related to surgical sutures marketed in Brazil |
title_full |
Adverse events and technical complaints related to surgical sutures marketed in Brazil |
title_fullStr |
Adverse events and technical complaints related to surgical sutures marketed in Brazil |
title_full_unstemmed |
Adverse events and technical complaints related to surgical sutures marketed in Brazil |
title_sort |
Adverse events and technical complaints related to surgical sutures marketed in Brazil |
author |
Morais, Luciene de Oliveira |
author_facet |
Morais, Luciene de Oliveira Friedrich, Karen Melchior, Stela Candioto Silva, Michele Feitoza Gemal, André Luis Delgado, Isabella Fernandes |
author_role |
author |
author2 |
Friedrich, Karen Melchior, Stela Candioto Silva, Michele Feitoza Gemal, André Luis Delgado, Isabella Fernandes |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Morais, Luciene de Oliveira Friedrich, Karen Melchior, Stela Candioto Silva, Michele Feitoza Gemal, André Luis Delgado, Isabella Fernandes |
dc.subject.por.fl_str_mv |
surgical sutures technical surveillance sanitary surveillance notivisa fio para sutura cirúrgica tecnovigilância vigilância sanitária notivisa |
topic |
surgical sutures technical surveillance sanitary surveillance notivisa fio para sutura cirúrgica tecnovigilância vigilância sanitária notivisa |
description |
Surgical suture (SS) is a medical material used invasively for positioning biological tissues and is regarded as a critical product due to its contact with skin, vessels and other tissues. The present study aimed to critically analyze the Brazilian National Adverse Event and Product Complaint Reporting (Notivisa) data related to SS. Descriptions of reports made between 2006 and 2009 were thoroughly evaluated. There were 256 reports associated with SS, of which 94 (36.7%) were related to adverse events and 162 (63.3%) to product complaints. The analysis of Notivisa data showed some conceptual inconsistencies and incomplete reports. Most reports were related to suture products including low tensile strength and breaking as well as problems with suture needles. The reports analyzed involved 51% of surgical suture companies doing business in Brazil and there was more than one reporting for 28 batches. These findings stress the importance of implementing a compulsory product certification system with mandatory minimum quality requirements and show a need for ongoing training of those involved in the reporting process. More accurate, faster reporting process would support timely action by health surveillance agents and product companies to prevent or minimize unfavorable health outcomes in the exposed populations. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-05-29 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion "Peer-reviewed article" "Artículo revisado por pares" "Artigo avaliado pelos pares" |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/25 10.3395/vd.v1n2.25 |
url |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/25 |
identifier_str_mv |
10.3395/vd.v1n2.25 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/25/27 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/25/582 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/25/583 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/25/584 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/25/585 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/msword application/msword application/msword application/msword |
dc.publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
dc.source.none.fl_str_mv |
Health Surveillance under Debate: Society, Science & Technology ; Vol. 1 No. 2 (2013): May; 35-43 Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 1 Núm. 2 (2013): Puede; 35-43 Vigil Sanit Debate, Rio de Janeiro; v. 1 n. 2 (2013): Maio; 35-43 2317-269X reponame:Vigilância Sanitária em Debate instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Vigilância Sanitária em Debate |
collection |
Vigilância Sanitária em Debate |
repository.name.fl_str_mv |
Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br |
_version_ |
1797042043317387264 |